Cited by 405Cytokine Signaling Pathways and InteractionsPsoriasis: Treatment and PathogenesisIL-33, ST2, and ILC Pathways

Cutting Edge: STAT Activation By IL-19, IL-20 and mda-7 Through IL-20 Receptor Complexes of Two Types

Open access
Dumoutier, Laure, Leemans, Caroline, Lejeune, Diane, Kotenko, Sergei V, Renauld, Jean-Christophe·2001·The Journal of Immunology

Abstract

IL-10-related cytokines include IL-20 and IL-22, which induce, respectively, keratinocyte proliferation and acute phase production by hepatocytes, as well as IL-19, melanoma differentiation-associated gene 7, and AK155, three cytokines for which no activity nor receptor complex has been described thus far. Here, we show that mda-7 and IL-19 bind to the previously described IL-20R complex, composed by cytokine receptor family 2–8/IL-20Rα and DIRS1/IL-20Rβ (type I IL-20R). In addition, mda-7 and IL-20, but not IL-19, bind to another receptor complex, composed by IL-22R and DIRS1/IL20Rβ (type II IL-20R). In both cases, binding of the ligands results in STAT3 phosphorylation and activation of a minimal promoter including STAT-binding sites. Taken together, these results demonstrate that: 1) IL-20 induces STAT activation through IL-20R complexes of two types; 2) mda-7 and IL-20 redundantly signal through both complexes; and 3) IL-19 signals only through the type I IL-20R complex.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.4049/jimmunol.167.7.3545

Cites

17 of 17 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • IL-22 mediates its functions by binding to its heterodimeric receptor consisting of IL-10 receptor β2 (IL-10Rβ2) and IL-22 receptor (IL-22R) and activating signaling pathways that stimulate STAT3 phosphorylation and nuclear translocation.

    “IL-22 mediates its functions by binding to its heterodimeric receptor consisting of IL-10 receptor β2 (IL-10Rβ2) and IL-22 receptor (IL-22R) and activating signaling pathways, which stimulate STAT3 phosphorylation and nuclear translocation.80–84”

    From The Innate Immune System in Acute and Chronic Wounds (2016) · cites this paper as [80]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. Dumoutier, L., E. Van Roost, D. Colau, and J.-C. Renauld. 2000. Human IL-TIF: molecular cloning and functional characterization as an hepatocyte stimulating factor. Proc. Natl. Acad. Sci. USA 97:10144.

Cited by

Sorted by citations

Authors
Dumoutier, L., Leemans, C., Lejeune, D., Kotenko, S. V., & Renauld, J.-C.
Affiliations
  • Ludwig Cancer Research (BE)
  • Rutgers New Jersey Medical School (US)
Venue
The Journal of Immunology
Published
2001-10-01
Volume
167
Issue
7
Pages
3545-3549
ISSN
  • 0022-1767 (ISSN-L)
  • 1550-6606
OpenAlex
W2128229361
Cited by
405
References
17
Citations by year
2026: 6 · 2025: 11 · 2024: 10 · 2023: 7 · 2022: 8 · 2021: 13 · 2020: 10 · 2019: 14 · 2018: 11 · 2017: 18 · 2016: 16 · 2015: 15 · 2014: 18 · 2013: 15 · 2012: 17
FWCI
10.49
Type
journal article
Language
en
Open access
Locations
  • The Journal of Immunology (publishedVersion)
  • PubMed (publishedVersion)
  • Digital Access to Libraries (submittedVersion)
Funders
National Institute of Allergy and Infectious Diseases (R01AI051139, R01AI51139)
Topics
  • Health Sciences › Medicine › Oncology › Cytokine Signaling Pathways and Interactions
  • Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
  • Life Sciences › Immunology and Microbiology › Immunology › IL-33, ST2, and ILC Pathways
Keywords
STAT3 activation, IL-19, IL-20, MDA-7, IL-20 receptor, IL-22 receptor, cytokine receptor signaling, STAT3 phosphorylation
MeSH terms
Interleukin-22, Interleukin-24, Carrier Proteins, Cell Line, DNA-Binding Proteins, Growth Substances, Humans, Interleukins, Models, Biological, Receptors, Cell Surface, Transfection, Signal Transduction, Transcriptional Activation, Trans-Activators, Genes, Tumor Suppressor, Interleukin-10, Genes, Reporter, Receptors, Interleukin, Macromolecular Substances, STAT3 Transcription Factor

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review